Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 85,346 shares at $30.06 ($2.6M) on 2016-08-31, disclosed to the SEC on 2016-09-02.
Open-market sale of $2.6M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.06 | 42,673 | $1.3M | 50.0% |
| 2 | $30.06 | 42,673 | $1.3M | 50.0% |
| Total | $30.06 avg | 85,346 | $2.6M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-21 | $4.9M | — | Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $8.9M | — | Filing → |